On average, people taking Wegovy lost 16.9% of their body weight, compared to 2-3% for those taking a placebo
Doctronic.ai can connect you with telehealth consultations to discuss whether professional treatment makes sense for your situation
Pathophysiology and diagnostic value of urinary trypsin inhibitors
10.3389/fnbeh.2021.675206 Summary Keywords microbiotagutbrain axis, neurodegenerative diseases, microplastics, gut dysbiosis, neuropsychiatric disorders, microbiome-based interventions, neuroinflammation Citation Yassin LK, Skrabulyte-Barbulescu J, Alshamsi SH, Saeed S, Alkuwaiti SH, Almazrouei S, Alnuaimi A, BaniYas S, Aldhaheri D, Alderei M, Shehab S and Hamad MIK (2025) The microbiotagutbrain axis in mental and neurodegenerative disorders: opportunities for prevention and intervention
Because they suppress appetite, these medications reduce food intake, leaving people feeling full for longer periods